161 related articles for article (PubMed ID: 37085806)
1. Metabolic syndrome among people living with HIV on antiretroviral therapy in Mwanza, Tanzania.
Malindisa E; Balandya E; Njelekela M; Kidenya BR; Francis F; Mmbaga BT; Dika H; Lyamuya E; Sunguya B; Bartlett J; PrayGod G
BMC Endocr Disord; 2023 Apr; 23(1):88. PubMed ID: 37085806
[TBL] [Abstract][Full Text] [Related]
2. Metabolic syndrome in Zambian adults with human immunodeficiency virus on antiretroviral therapy: Prevalence and associated factors.
Hamooya BM; Mulenga LB; Masenga SK; Fwemba I; Chirwa L; Siwingwa M; Halwiindi H; Koethe JR; Lipworth L; Heimburger DC; Musonda P; Mutale W
Medicine (Baltimore); 2021 Apr; 100(14):e25236. PubMed ID: 33832083
[TBL] [Abstract][Full Text] [Related]
3. Prevalence and characteristics of metabolic syndrome and its components among adults living with and without HIV in Nigeria: a single-center study.
Jumare J; Dakum P; Sam-Agudu N; Memiah P; Nowak R; Bada F; Oguama U; Odonye G; Adebiyi R; Cairo C; Kwaghe V; Adebamowo C; Abimiku A; Charurat M
BMC Endocr Disord; 2023 Jul; 23(1):160. PubMed ID: 37507703
[TBL] [Abstract][Full Text] [Related]
4. Prevalence of, risk factors for, and target organ damage from metabolic syndrome among people living with HIV on ART: A cross-sectional analysis in Chongqing, China.
Liu M; He K; Wu Y; Yu Q; Sun N; Teng X; Meng X; Yuan J; Yang H
HIV Med; 2024 May; 25(5):529-539. PubMed ID: 38158594
[TBL] [Abstract][Full Text] [Related]
5. Metabolic Syndrome Among Antiretroviral Therapy-Naive Versus Experienced HIV-Infected Patients Without Preexisting Cardiometabolic Disorders in Western Kenya.
Osoti A; Temu TM; Kirui N; Ngetich EK; Kamano JH; Page S; Farquhar C; Bloomfield GS
AIDS Patient Care STDS; 2018 Jun; 32(6):215-222. PubMed ID: 29851503
[TBL] [Abstract][Full Text] [Related]
6. An observational study of the prevalence of metabolic syndrome in treatment-experienced people living with HIV in Singapore.
Ang LW; Ng OT; Boudville IC; Leo YS; Wong CS
PLoS One; 2021; 16(6):e0252320. PubMed ID: 34077481
[TBL] [Abstract][Full Text] [Related]
7. The prevalence of metabolic syndrome and associated factors among adults on antiretroviral therapy in Dar es Salaam, Tanzania.
Yusufu I; Nagu T; Ottaru TA; Sando MM; Kaaya S; Mbugi E; Hirschhorn LR; Hawkins C
Res Sq; 2024 May; ():. PubMed ID: 38798337
[TBL] [Abstract][Full Text] [Related]
8. Prevalence, treatment, and factors associated with cryptococcal meningitis post introduction of integrase inhibitors antiretroviral based regimens among People Living with HIV in Tanzania.
Minja M; Mbilinyi T; Mkinga B; Philipo EG; Owenya J; Kilonzi M
PLoS One; 2024; 19(2):e0294940. PubMed ID: 38412200
[TBL] [Abstract][Full Text] [Related]
9. Metabolic syndrome in patients on first-line antiretroviral therapy containing zidovudine or tenofovir in rural Lesotho, Southern Africa.
Labhardt ND; Müller UF; Ringera I; Ehmer J; Motlatsi MM; Pfeiffer K; Hobbins MA; Muhairwe JA; Muser J; Hatz C
Trop Med Int Health; 2017 Jun; 22(6):725-733. PubMed ID: 28342180
[TBL] [Abstract][Full Text] [Related]
10. Metabolic syndrome among treatment-naïve people living with and without HIV in Zambia and Zimbabwe: a cross-sectional analysis.
Chihota BV; Mandiriri A; Shamu T; Muula G; Nyamutowa H; Taderera C; Mwamba D; Chilengi R; Bolton-Moore C; Bosomprah S; Egger M; Chimbetete C; Wandeler G;
J Int AIDS Soc; 2022 Dec; 25(12):e26047. PubMed ID: 36522287
[TBL] [Abstract][Full Text] [Related]
11. Prevalence and risk factors of metabolic syndrome in Ethiopia: describing an emerging outbreak in HIV clinics of the sub-Saharan Africa - a cross-sectional study.
Abdela AA; Yifter H; Reja A; Shewaamare A; Ofotokun I; Degu WA
BMJ Open; 2023 Dec; 13(12):e069637. PubMed ID: 38070936
[TBL] [Abstract][Full Text] [Related]
12. Metabolic syndrome in people living with antiretroviral therapy: A cross-sectional investigation from Pune, India.
Shidhaye P; Ghate M; Gurav S; Gupte MD; Panda S
Indian J Public Health; 2023; 67(1):84-91. PubMed ID: 37039211
[TBL] [Abstract][Full Text] [Related]
13. Dysglycemia associations with adipose tissue among HIV-infected patients after 2 years of antiretroviral therapy in Mwanza: a follow-up cross-sectional study.
PrayGod G; Changalucha J; Kapiga S; Peck R; Todd J; Filteau S
BMC Infect Dis; 2017 Jan; 17(1):103. PubMed ID: 28137307
[TBL] [Abstract][Full Text] [Related]
14. Association of Helicobacter pylori infection with the metabolic syndrome among HIV-infected black Africans receiving highly active antiretroviral therapy.
Longo-Mbenza B; Apalata T; Longokolo M; Mambimbi MM; Mokondjimobe E; Gombet T; Ellenga B; Buassa-bu-Tsumbu B; Dipa GM; Luila EL; Nge Okwe A
Cardiovasc J Afr; 2015; 26(2):52-6. PubMed ID: 25940117
[TBL] [Abstract][Full Text] [Related]
15. Prevalence of metabolic syndrome among people living with human immunodeficiency virus in sub-Saharan Africa: a systematic review and meta-analysis.
Asgedom YS; Kebede TM; Gebrekidan AY; Koyira MM; Azeze GA; Lombebo AA; Efa AG; Haile KE; Kassie GA
Sci Rep; 2024 May; 14(1):11709. PubMed ID: 38777850
[TBL] [Abstract][Full Text] [Related]
16. Influences of gender in metabolic syndrome and its components among people living with HIV virus using antiretroviral treatment in Hawassa, southern Ethiopia.
Hirigo AT; Tesfaye DY
BMC Res Notes; 2016 Mar; 9():145. PubMed ID: 26945987
[TBL] [Abstract][Full Text] [Related]
17. High prevalence of low high-density lipoprotein cholesterol and insulin resistance among children and adolescents living with HIV in Uganda: harbinger for metabolic syndrome?
Kisitu G; Shabanova V; Naiga F; Nakagwa M; Kekitiinwa AR; Elyanu PJ; Paintsil E
HIV Med; 2024 Feb; 25(2):262-275. PubMed ID: 37879630
[TBL] [Abstract][Full Text] [Related]
18. Knowledge and perception on type2 diabetes and hypertension among HIV clients utilizing care and treatment services: a cross sectional study from Mbeya and Dar es Salaam regions in Tanzania.
Kagaruki GB; Mayige MT; Ngadaya ES; Kilale AM; Kahwa A; Shao AF; Kimaro GD; Manga CM; Mbata D; Materu GS; Masumo RM; Mfinanga SG
BMC Public Health; 2018 Jul; 18(1):928. PubMed ID: 30055591
[TBL] [Abstract][Full Text] [Related]
19. [Metabolic syndrome among people with HIV in central Tunisia: Prevalence and associated factors].
Aouam A; Marmouch H; Kooli I; Marrakchi W; Hellara I; Neffati F; Najjar F; Chakroun M
Ann Pharm Fr; 2021 Jul; 79(4):465-472. PubMed ID: 33516719
[TBL] [Abstract][Full Text] [Related]
20. Weight changes, metabolic syndrome and all-cause mortality among Asian adults living with HIV.
Han WM; Law MG; Choi JY; Ditangco R; Kumarasamy N; Chaiwarith R; Ly PS; Khusuwan S; Merati TP; Do CD; Yunihastuti E; Azwa I; Lee MP; Pham TN; Chan YJ; Kiertiburanakul S; Ng OT; Tanuma J; Pujari S; Zhang F; Gani Y; Mave V; Ross J; Avihingsanon A;
HIV Med; 2022 Mar; 23(3):274-286. PubMed ID: 34816562
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
